GENERAL ATLANTIC, L.P. Diversified Active

Location: New York, NY

CIK: 0001017645 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 14, 2025

Total Value: $2.979B (100.0% shares, 0.0% debt)

Holdings (15)

ALHC ALIGNMENT HEALTHCARE 38.1%

Value $1.136B Shares 60,993,323 Share Price $18.62 Est. Cost/Share — Unrealized @ Report Date —

DLO DLOCAL 17.9%

Value $533M Shares 63,906,695 Share Price $8.34 Est. Cost/Share — Unrealized @ Report Date —

XP XP, INC 13.7%

Value $407M Shares 29,617,733 Share Price $13.75 Est. Cost/Share — Unrealized @ Report Date —

ALKT ALKAMI 8.5%

Value $253M Shares 9,645,318 Share Price $26.25 Est. Cost/Share — Unrealized @ Report Date —

— AKERO THERAPEUTICS 7.1%

Value $212M Shares 5,233,989 Share Price $40.48 Est. Cost/Share — Unrealized @ Report Date —

CNTA CENTESSA PHARMACEUTICALS 4.7%

Value $139M Shares 9,681,818 Share Price $14.38 Est. Cost/Share — Unrealized @ Report Date —

PHVS PHARVARIS 4.0%

Value $118M Shares 7,531,252 Share Price $15.70 Est. Cost/Share — Unrealized @ Report Date —

EWCZ EUROPEAN WAX CENTER 1.7%

Value $51.79M Shares 13,110,492 Share Price $3.95 Est. Cost/Share — Unrealized @ Report Date —

RPRX ROYALTY PHARMA 1.6%

Value $46.7M Shares 1,500,000 Share Price $31.13 Est. Cost/Share — Unrealized @ Report Date —

IMCR IMMUNOCORE 1.3%

Value $37.43M Shares 1,261,684 Share Price $29.67 Est. Cost/Share — Unrealized @ Report Date —

RSKD RISKIFIED 0.8%

Value $24.6M Shares 5,324,998 Share Price $4.62 Est. Cost/Share — Unrealized @ Report Date —

— ACELYRIN 0.2%

Value $6.657M Shares 2,695,327 Share Price $2.47 Est. Cost/Share — Unrealized @ Report Date —

ADAG ADAGENE 0.2%

Value $5.815M Shares 3,825,952 Share Price $1.52 Est. Cost/Share — Unrealized @ Report Date —

Value $4.255M Shares 609,616 Share Price $6.98 Est. Cost/Share — Unrealized @ Report Date —

GROV GROVE COLLABORATIVE 0.1%

Value $3.341M Shares 2,474,859 Share Price $1.35 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
ALHC	ALIGNMENT HEALTHCARE	60,993,323	$1.136B	38.1%	$18.62	—	—	COM	01625V104
DLO	DLOCAL	63,906,695	$533M	17.9%	$8.34	—	—	CL A	G29018101
XP	XP, INC	29,617,733	$407M	13.7%	$13.75	—	—	CL A	G98239109
ALKT	ALKAMI	9,645,318	$253M	8.5%	$26.25	—	—	COM	01644J108
—	AKERO THERAPEUTICS	5,233,989	$212M	7.1%	$40.48	—	—	COM	00973Y108
CNTA	CENTESSA PHARMACEUTICALS	9,681,818	$139M	4.7%	$14.38	—	—	ADS	152309100
PHVS	PHARVARIS	7,531,252	$118M	4.0%	$15.70	—	—	COM	N69605108
EWCZ	EUROPEAN WAX CENTER	13,110,492	$51.79M	1.7%	$3.95	—	—	CL A	29882P106
RPRX	ROYALTY PHARMA	1,500,000	$46.7M	1.6%	$31.13	—	—	CL A	G7709Q104
IMCR	IMMUNOCORE	1,261,684	$37.43M	1.3%	$29.67	—	—	ADS	45258D105
RSKD	RISKIFIED	5,324,998	$24.6M	0.8%	$4.62	—	—	CL A	M8216R109
—	ACELYRIN	2,695,327	$6.657M	0.2%	$2.47	—	—	COM	00445A100
ADAG	ADAGENE	3,825,952	$5.815M	0.2%	$1.52	—	—	ADS	005329107
—	WISH	609,616	$4.255M	0.1%	$6.98	—	—	CL A	21077C305
GROV	GROVE COLLABORATIVE	2,474,859	$3.341M	0.1%	$1.35	—	—	CL A	39957D201